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Autism spectrum disorder (ASD) is a serious
developmental disability characterized by def-
icits of communication and social interaction
and often accompanied by restricted or re-
petitive behaviors. Recent surveillance efforts
estimate ASD to occur in 1 in 68 US children
aged 8 years, with rapid increases in identified
incidence over the past decade.1 Numerous
studies have investigated the causes and cor-
relates of autism and ASD, commonly finding
male gender2,3; prenatal and perinatal fac-
tors,4---6 such as preterm birth, low birth weight,
and gestational diabetes; and parental charac-
teristics, such as higher socioeconomic status5
and education,2,5 older parental age,2,3,7,8
White race,2,5 and history of psychiatric con-
ditions4 to be associated with autism. In addi-
tion, there is a large but complex genetic
component with a subset of inherited familial
autism cases as well as an important role for
rare and common copy number variations.9---11
As autism diagnoses have risen, the use of
assisted reproductive technology (ART), de-
fined as in vitro fertilization (IVF) and similar
procedures in which both egg and sperm are
handled, has increased rapidly.12 In a typical
ART procedure, fresh or frozen egg and sperm
from donors or from 1 or both of the parents
are combined in a laboratory for fertilization
and cultured for several days before implanta-
tion in a woman’s uterus.13 Often hormonal
medication is used to stimulate or regulate
ovulation. There are several variations, in-
cluding IVF with intracytoplasmic sperm in-
jection, in which the egg is fertilized by injecting
the sperm directly into the egg, and less
common procedures, in which the fertilized
embryo, or a mixture of sperm and eggs, is
placed in the fallopian tubes rather than the
uterus (zygote intrafallopian transfer and gam-
ete intrafallopian transfer, respectively). Often,
multiple embryos are transferred to maximize
the probability of implantation and pregnancy,
producing a high rate of twin and higher-order
multiple births from ART. In recent years, the
Society for Assisted Reproductive Technology
and the American Society for Reproductive
Medicine have issued voluntary guidelines re-
garding the number of embryos to transfer for
various patient types, which has resulted in
a reduction in multiple births.14
ART-originated pregnancies share many of
the correlates of autism, including parents who
are older and have higher levels of education
and multiple births, preterm delivery, preg-
nancy and labor complications, low birth
weight, and other birth defects and develop-
mental disabilities. Further, the use of ART
contributes to the preexisting trend of older
parents by pushing on the upper boundary
of the fertile age range.
A few studies have investigated the rela-
tionship between ART conception and the risk
of developmental disabilities and autism di-
agnoses; however, results are mixed and in-
conclusive.15---25 For example, some studies
have found no differences between children
originated with ART and control groups of
children with regard to congenital malforma-
tion or developmental delay,26 but others have
found increased risks of emotional distur-
bances,27 lower cognitive and language skills,28
and cerebral palsy.20 In a recent review of the
evidence on the ART---autism association 8
studies, many with design limitations including
short follow-up periods and insufficient sample
sizes, showed inconsistent results.20 Most
studies that have examined ART outcomes
have failed to collect data from participants
older than 2 years29; this is a problem because
autism is often diagnosed when a child is older
than 4 years.1 One recent case-control study
found no association, although there was
some evidence of a link between less severe
forms of ASD and artificial insemination and
ovulation-induction treatment among older
mothers.23 A study of children with ASD found
no evidence of increased copy number varia-
tions or other autism-related genetic events
among children originated with ART.30
Objectives. We assessed the association between assisted reproductive tech-
nology (ART) and diagnosed autistic disorder in a population-based sample of
California births.
Methods. We performed an observational cohort study using linked records
from the California Birth Master Files for 1997 through 2007, the California
Department of Developmental Services autism caseload for 1997 through 2011,
and the Centers for Disease Control and Prevention’s National ART Surveil-
lance System for live births in 1997 through 2007. Participants were all 5 926 251
live births, including 48 865 ART-originated infants and 32 922 cases of autism
diagnosed by the Department of Developmental Services. We compared births
originated using ART with births originated without ART for incidence of
autism.
Results. In the full population, the incidence of diagnosed autism was twice as
high for ART as non-ART births. The association was diminished by excluding
mothers unlikely to use ART; adjustment for demographic and adverse prenatal
and perinatal outcomes reduced the association substantially, although statis-
tical significance persisted for mothers aged 20 to 34 years.
Conclusions. The association between ART and autism is primarily explained
by adverse prenatal and perinatal outcomes and multiple births. (Am J Public
Health. 2015;105:963–971. doi:10.2105/AJPH.2014.302383)
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The best evidence comes from several well-
designed Scandinavian studies using large
population-level registry databases. A Danish
study found an elevated risk of autism for infants
originated through ART, although the difference
was not statistically significant after adjustments.18
However, this study did find elevated risks for
certain subgroups, notably girls and those born
after ovarian stimulation treatment. Another
Danish registry study found no increased risk of
childhood and adolescent psychological disorders
resulting from IVF, but they did find a slightly
elevated risk of autism and several other disor-
ders arising from ovulation induction and assisted
insemination.25 Similarly, a recent Swedish study
found no elevated risk of autism from IVF, but
it did find a significant risk from certain subtypes
of IVF procedures as well as an elevated risk
of intellectual disability. Both studies suggest
the importance of further research on large
population-level data sets.
Because of the increasing use of ART as
well as the increasing incidence and uncertain
etiology of autism, it is important to explore
whether these phenomena are associated. We
assessed the possible association between ART
and diagnosed autism in a 10-year cohort of
California children.
METHODS
We constructed the data set from 3 sources:
the California Birth Master Files for 1997---2007,
the California Department of Developmental
Services (DDS) autism caseload records for
1997---2011, and the Centers for Disease Control
and Prevention’s National ART Surveillance
System for live births for 1997---2007.
The variables we extracted from the Cali-
fornia birth records included maternal and
paternal age at birth; maternal education, race/
ethnicity, and birthplace; infant gender and
birth weight and the duration of gestation;
plurality; parity; pregnancy and birth compli-
cations; mode of delivery; source of payment
for labor and delivery; and quantity of prenatal
care. We derived variables known to be asso-
ciated with autism and ART, including preterm
birth (less than 37 weeks) and small for
gestational age (weight below the 10th per-
centile for the gestational age).
The DDS system coordinates diagnoses,
services, and support for persons with
developmental disabilities in California, in-
cluding patients with autistic disorder (Diag-
nostic and Statistical Manual of Mental Disor-
ders, Fourth Edition31 [DSM-IV] code 299.0)
but generally not those with other ASDs such
as Asperger’s syndrome. The vast majority of
persons with autism in California are enrolled
in the DDS, making it the largest administrative
source of data on autism diagnoses.32 We
classified children enrolled in the DDS autism
caseload as having a diagnosis of autism on the
date of enrollment. We did not identify autism
cases through population surveillance, so in-
cidence may underestimate the true incidence
rate. When we use the term “incidence” we
refer specifically to incidence of DDS-identified
autistic disorder as diagnosed per the DSM-IV.
The Division of Reproductive Health of the
Centers for Disease Control and Prevention
collects and maintains the National ART Sur-
veillance System, a registry of all ART cycles
initiated in US fertility clinics. Reporting is
mandatory,33 and it is estimated that at least
95% of all ART cycles are represented in the
database.34 The registry collects data for all
ART procedures in which both gametes are
handled (i.e., IVF, gamete intrafallopian
transfer, intrafallopian transfer) but not pro-
cedures such as intrauterine insemination
or ovulation-induction treatment.
The Society for Assisted Reproductive
Technology collected the information on each
ART procedure from ART clinics for the years
1997 through 2003 and Westat collected it
for the years 2004 through 2007.
Linking Procedures
We selected the subset of ART procedures
that led to a live birth and were performed at
an ART clinic in California. All types of ART
procedures, including IVF with and without
intracytoplasmic sperm injection, intrafallopian
transfer, and gamete intrafallopian transfer, are
included in this group. We found ART births in
the California Birth Master Files using Link Plus
2.0 software,35 on the basis of mother’s date of
birth, infant’s date of birth, plurality, mother’s
zip code, and gravidity. We manually reviewed
uncertain matches, and we used infant gender,
maternal race, and infant birth weight to re-
solve duplicate or uncertain matches. We
successfully linked 90% of ART births to
a California birth, which is similar to that of
previous links of ART surveillance data with
birth certificate data previously conducted and
validated with high reliability as part of the
States Monitoring ART Collaborative project in
other states.36
We linked autism cases from the DDS
probabilistically to the California Birth Master
Files on first and last names, middle initial, date
of birth, gender, race/ethnicity, and maternal
zip code. We manually reviewed uncertain
matches. On average, we linked 86% of eligible
children with autism in the DDS database to
a birth record. Typically, unmatched DDS re-
cords were of children born outside California
who moved into the state after birth.37
Statistical Analysis
We calculated frequencies and percentages
summarizing the demographic composition
and selected autism risk factors for ART-
originated and naturally originated infants.
We have reported P values for the v2 test of
association between each variable and ART
use. We analyzed 2 different samples: (1) total
1997 to 2007 California resident birth cohort,
and (2) an analysis subset of children designed
to exclude children of mothers who are very
different from the typical ART patient and to
eliminate ascertainment bias stemming from
differences in the use of medical care.38
The analysis subset excluded infants whose
mothers were younger than 20 years, had less
than a high school education, had prenatal care
or delivery paid for by Medi-Cal or another
public source, or had missing information on
prenatal care or inadequate prenatal care39
or started prenatal care in the third trimester.
Each of these exclusion categories included
a very small percentage of ART-originated
children (Table 1), so sample restriction was
preferable to statistical adjustment for these
specific factors. Additionally, we eliminated
observations missing values for any of the
model covariates from the sample (about 4%).
The large sample and small percentage of
missing data made listwise deletion preferable
to multiple imputation or other strategies.40
This left a total of 2 420 330 children in the
analysis subset; altogether, we excluded
3 505 921 mother---child pairs.
We calculated diagnosed autism incidence
with robust 95% confidence intervals (CIs)
adjusted for multiple deliveries, for ART and
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TABLE 1—Percentage Distribution of Key Variables by ART and Autism Status: California 1997–2007
Variable Non-ART (n = 5 877 386), % ART (n = 48 865), % Pa No Autism (n = 5 893 329), % Autism (n = 32 922), % Pa
Birth year £ .001 £ .001
1997 8.9 4.1 8.9 7.2
1998 8.8 5.5 8.8 7.8
1999 8.8 5.9 8.8 8.1
2000 9.0 6.4 9.0 9.1
2001 8.9 8.3 8.9 9.6
2002 8.9 9.8 8.9 10.2
2003 9.1 10.9 9.1 11.0
2004 9.2 11.6 9.2 10.5
2005 9.3 11.9 9.3 10.0
2006 9.5 12.2 9.5 9.1
2007 9.5 13.3 9.6 7.4
Infant’s gender .335 £ .001
Female 48.9 49.1 49.0 16.8
Male 51.1 50.9 51.0 83.2
Plurality £ .001 £ .001
Singleton 97.5 47.3 97.1 94.8
Twin 2.4 46.4 2.8 4.8
Triplet or more 0.1 6.4 0.1 0.4
Parity £ .001 £ .001
Multiparous 61.3 49.6 61.3 56.6
Primiparous 38.7 50.4 38.7 43.4
Mother’s age, y £ .001 £ .001
< 20 10.2 0.0 10.1 5.1
20–24 23.2 0.4 23.1 17.8
25–29 26.5 6.5 26.3 25.4
30–34 24.0 27.7 24.0 28.0
35–39 13.0 37.4 13.1 18.5
‡ 40 3.1 28.0 3.3 5.2
Mother’s race £ .001 £ .001
Non-Hispanic White 30.6 67.7 30.9 34.4
Black 6.3 2.4 6.2 7.4
Hispanic 49.8 11.1 49.5 40.8
Asian or Pacific Islander 11.9 16.2 11.9 16.0
Native American 0.5 0.2 0.4 0.4
Other or unknown 1.0 2.5 1.0 1.0
Mother’s birthplace £ .001 £ .001
US and US territories 54.1 72.1 54.3 56.3
Outside US 45.9 27.9 45.7 43.7
Mother’s education £ .001 £ .001
< high school diploma 30.3 2.2 30.2 18.8
High school diploma 27.8 9.5 27.6 26.2
Some college 20.0 18.2 19.9 24.9
‡ 4-y college graduate 21.9 70.1 22.3 30.1
Small for gestational age £ .001 £ .001
‡ 10th percentile 90.4 78.1 90.4 89.2
< 10th percentile 9.6 21.9 9.6 10.8
Continued
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natural conceptions, for all children by plurality
group, and for the analysis subset. We esti-
mated hazard risk ratios (HRRs), with robust
sandwich SEs to adjust for clustering on family
ID, for the hazard of autism diagnosis among
children originated with ART compared with
those originated without ART.41 Children born
in later years were observed for a shorter
period, potentially introducing ascertainment
bias; we adjusted for this difference statistically
by including indicator variables for birth years.
We estimated 3 sets of adjusted models on
the analysis subset. Model 1 included demo-
graphic factors only: year of birth, infant
gender, maternal education (college gradu-
ate or not), and maternal race (non-Hispanic
White, Black, Asian, Hispanic, and other).
Model 2 was the main adjusted model and
it included all variables in model 1 plus
factors associated with both ART and au-
tism that might have an underlying biolog-
ical impact on pregnancy health and fetal
development: maternal age (20---34 years or
‡35 years) and parity and an interaction
between maternal age and ART.
Model 3 included all variables in model 2
plus adverse perinatal outcomes previously
associated with both ART and autism: multiple
birth, preterm delivery (< 37 weeks), small for
gestational age (< 10th percentile), maternal
diabetes, pregnancy hypertension or pre-
eclampsia, and cesarean delivery. These are
outcomes that occur after conception and thus
TABLE 1—Continued
Preterm £ .001 £ .001
‡ 37 wk 89.5 63.8 89.3 86.6
< 37 wk 10.5 36.2 10.7 13.4
Hypertension or preeclampsia £ .001 £ .001
None recorded 97.5 92.8 97.5 96.6
Present 2.5 7.2 2.5 3.4
Maternal diabetes £ .001 £ .001
None recorded 98.0 96.9 98.0 97.0
Present 2.0 3.1 2.0 3.0
Mode of delivery £ .001 £ .001
Vaginal 73.7 35.5 73.4 65.3
Cesarean 26.3 64.5 26.6 34.7
Trimester prenatal care begun £ .001
None 0.6 0.1 0.6 0.3
First 84.8 96.7 84.9 88.8
Second 12.2 3.0 12.1 9.3
Third 2.4 0.2 2.4 1.6
Payment source for prenatal care £ .001 £ .001
Private insurance or payment 54.3 97.0 54.6 64.6
Public source 45.7 3.0 45.4 35.4
Payment source for delivery £ .001 £ .001
Private insurance or payment 53.9 97.0 54.2 64.3
Public source 46.1 3.0 45.8 35.7
Adequacy of prenatal care £ .001 £ .001
Missing 3.0 2.3 3.0 2.4
Inadequate 9.6 1.2 9.6 6.8
Intermediate 12.7 4.7 12.6 11.2
Adequate 41.3 22.2 41.1 40.3
Adequate plus 33.5 69.6 33.7 39.3
DDS autism status £ .001 £ .001
No autism 99.4 98.8
Autism 0.6 1.2
Originated using ART? £ .001
No 99.2 98.2
Yes 0.8 1.8
Note. ART = assisted reproductive technology; DDS = California Department of Developmental Services.
aWe derived P values from the v2 test for association between categorical predictor variable and ART conception or autism status.
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are not properly considered confounders but
rather potential pathways or mechanisms
through which ART and autism may be asso-
ciated. The HRR for the effect of ART on
autism in model 3 represents only any direct
effect, not the indirect association created
because ART pregnancies and deliveries tend
to have more complications and include more
multiple births.38,42---48 This is a simple way of
exploring the effect of mediators but is valid
only if the confounders of the relationship
between response and exposure are properly
accounted for, an assumption that is difficult to
confirm.49 However, we used our exclusion
strategy, combined with controls for con-
founders such as age and education, to
accomplish this as much as possible with
observational data.
Additionally, we estimated adjusted HRRs
within selected strata to assess possible effect
modifications. Stratified HRRs adjusted for all
variables in model 2 except the stratification
variable, and we conducted interaction tests for
all stratification variables. We conducted all
analyses using SAS, version 9.2 (SAS Institute,
Cary, NC).
RESULTS
Of the 5 926251 children born in California
from 1997 to 2007, 48 865 (0.83%) were
originated through ART and 32922 (0.56%)
were diagnosed with autism and enrolled in the
DDS caseload by June 2011. In bivariate
analyses, there were statistically significant
differences between ART- and non---ART-
originated children for all variables except
infant gender (Table 1). ART-originated chil-
dren were more likely to be born to highly
educated, older, non-Hispanic White, primipa-
rous mothers. Furthermore, ART-originated
infants had mothers with higher levels of pre-
natal care and were more likely to be twins
or higher-order multiples, to be born small
for gestational age, and to have mothers who
had complications of pregnancy and labor.
ART-originated infants were also more likely to
be diagnosed with autism. There were statisti-
cally significant differences between children
with autism and those without on all variables;
in particular, children with autism were more
likely to be boys; born in multiple births; born
to older,White, andmore educated mothers; and
born to mothers who have experienced compli-
cations of pregnancy and delivery.
Risk of Autism
ART-originated children had higher inci-
dence of DDS-diagnosed autism than did chil-
dren originated without ART. The groups
composed of triplets and higher-order multi-
ples had the highest incidence within each
conception group (Figure 1). In the total study
population of California births, diagnosed au-
tism incidence was about twice as high for ART
conceptions as for non---ART-originated chil-
dren (12.1 and 5.5, respectively, per 1000
births). In the analysis subset the pattern was
similar although attenuated: the incidence for
ART conceptions was 11.9 per 1000 births,
whereas the incidence for non-ART conception
was 7.0 per 1000 births.
Assisted Reproductive Technology,
Autism, and Additional Risk Factors
Table 2 shows the detailed results for the
covariates in several adjusted models on
the basis of the analysis subset. Other vari-
ables associated with autism included infant
gender, maternal age and race, and parity.
Complications of labor and pregnancy that
were associated with ART were also corre-
lated with eventual autism diagnosis. In
the total study population, children origi-
nated with ART had elevated incidence of
subsequent autism diagnosis (Figure 2;
HRR = 2.32; 95% CI = 2.12, 2.54). This in-
cidence was diminished but still elevated and
statistically significant in the analysis subset
(HRR = 1.79; 95% CI = 1.6, 2.0). Adjusting
for demographic factors (model 1) reduced
the HRR further: 1.71 (95% CI = 1.55,
1.89). Adjustment for maternal age and
parity (model 2) resulted in HRRs for risk of
autism of 1.74 (95% CI = 1.46, 2.07) for
children born to mothers aged 20 to 34
years and 1.37 (95% CI = 1.21, 1.54) for
children with mothers aged 35 years or older
(Table 2). The inclusion of adverse perinatal
outcomes occurring after conception (model
3) decreased the HRRs for ART to a rela-
tively small effect size; whereas it remained
marginally statistically significant for the
younger maternal age group (HRR = 1.21;
95% CI = 1.01, 1.45), the effect was reduced
to null for the older mothers (HRR = 1.00;
95% CI = 0.88, 1.14; Table 2).


















Note. ART = assisted reproductive technology.
FIGURE 1—Unadjusted prevalence of autism with 95% confidence intervals for all births by
plurality and, for the analysis subset, by ART conception status: California 1997–2007.
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Assisted Reproductive Technology and
Autism in Selected Strata
Figure 2b presents several strata-specific
adjusted HRRs for risk of autism. In each of
these models, we included all variables from
model 2 as potential confounders with the
exception of the stratification variable, and only
estimates for younger maternal ages are shown.
The adjusted HRR for autism was statistically
elevated for every subgroup except singletons.
The ART---autism association was stronger
among the subgroups that had a lower in-
cidence of diagnosed autism, such as girls,
second or greater births, and children whose
mothers were younger than 35 years when the
TABLE 2—Risk Factors for Autism Diagnosis and Associations With ART and All Covariates for Unadjusted and 3 Adjusted Models Estimated on
Analysis Subset (n = 2 420 330): California 1997–2007
Crude: Unadjusted,
HRR (95% CI)
Model 1: Adjusted for
Demographics,
HRR (95% CI)
Model 2: Model 1 + Mother’s
Age, Parity, HRR (95% CI)
Model 2 + Pathway
Factors, HRR (95% CI)
ART effect 1.790 (1.636, 1.959) 1.713 (1.551, 1.892)
For mothers aged 20–34 y 1.736 (1.457, 2.069) 1.210 (1.011, 1.448)
For mothers aged ‡ 35 y 1.365 (1.209, 1.541) 1.002 (0.881, 1.139)
Birth year
1997 0.666 (0.619, 0.717) 0.668 (0.621, 0.719) 0.679 (0.631, 0.731)
1998 0.709 (0.660, 0.761) 0.711 (0.662, 0.764) 0.721 (0.671, 0.774)
1999 0.771 (0.719, 0.827) 0.773 (0.720, 0.828) 0.782 (0.729, 0.838)
2000 0.850 (0.794, 0.909) 0.851 (0.795, 0.910) 0.858 (0.802, 0.918)
2001 0.914 (0.855, 0.977) 0.915 (0.856, 0.979) 0.919 (0.860, 0.983)
2002 (Ref) 1.000 1.000 1.000
2003 1.049 (0.983, 1.121) 1.046 (0.979, 1.117) 1.044 (0.978, 1.115)
2004 1.038 (0.970, 1.110) 1.033 (0.966, 1.105) 1.027 (0.960, 1.098)
2005 1.072 (1.001, 1.147) 1.066 (0.996, 1.141) 1.054 (0.984, 1.128)
2006 1.080 (1.006, 1.160) 1.070 (0.996, 1.149) 1.064 (0.990, 1.143)
2007 1.187 (1.101, 1.281) 1.177 (1.092, 1.270) 1.171 (1.085, 1.263)
Male infant 4.710 (4.524, 4.904) 4.710 (4.524, 4.904) 4.678 (4.493, 4.871)
Mother is college graduate 1.085 (1.050, 1.121) 1.009 (0.976, 1.0430) 1.013 (0.980, 1.047)
Mother’s race/ethnicity
Non-Hispanic White (Ref) 1.000 1.000 1.000
Black 1.431 (1.341, 1.527) 1.470 (1.378, 1.568) 1.416 (1.327, 1.511)
Asian 1.114 (1.062, 1.168) 1.124 (1.072, 1.180) 1.118 (1.065, 1.173)
Hispanic 1.012 (0.970, 1.055) 1.062 (1.018, 1.107) 1.053 (1.010, 1.098)
Other 1.012 (0.970, 1.055) 1.249 (0.999, 1.560) 1.232 (0.986, 1.540)
Mother is foreign-born 1.143 (1.099, 1.189) 1.129 (1.086, 1.174) 1.129 (1.085, 1.1740)
Primiparous 1.338 (1.297, 1.380) 1.335 (1.294, 1.3780)
Complications of pregnancy and
delivery on the causal pathway
Multiple birth 1.418 (1.304, 1.5410)
Small for gestational age 1.110 (1.057, 1.1660)
Preterm (< 37 wk) 1.181 (1.124, 1.240)
Maternal diabetes 1.276 (1.173, 1.3870)
Hypertension or preeclampsia 1.115 (1.027, 1.2110)
Cesarean delivery 1.272 (1.231, 1.3140)
–2Log L 498 555.79 490 104.63 489 471.22 488 900.48
AIC 498 557.79 490 140.63 489 513.22 488 954.48
Note. AIC = Aikake information criterion; ART = assisted reproductive technology; CI = confidence interval; HRR = hazard risk ratio. We calculated the effect of ART for all mothers aged ‡ 20 y for crude and
adjusted model 1. Model 1 includes demographic factors: year of birth, infant’s gender, and mother’s education and race. The estimated effect of ART is reported separately for mothers aged 20–34 and £ 35 y
for models 2 and 3 because of the presence of an interaction. Model 2 includes all variables in model 1 plus factors associated with both ART and autism that might have an underlying biological impact on
pregnancy health and fetal development: maternal age and parity and an interaction between mother’s age and ART. Model 3 includes all variables in model 2 plus perinatal outcomes previously associated with
both ART and autism: multiple birth, preterm delivery, small for gestational age, maternal diabetes, pregnancy hypertension or preeclampsia, and cesarean delivery. Estimates for baseline categories are omitted.
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infant was born and had a lower education
level. However, statistical tests for interaction
showed that only the maternal age and educa-
tion differentials were statistically significant.
DISCUSSION
We found an elevated incidence of diag-
nosed autism among children originated
through ART in the overall population as well
as among subgroups divided by plurality, par-
ity, infant gender, maternal age and education,
and paternal age. At the population level,
children originated with ART in California had
more than twice the incidence of autism of
children originated without ART. After ad-
justment for demographics and other factors
associated with both ART and autism, includ-
ing maternal age and parity, this increased
incidence remained statistically significant for
children born to mothers younger than 35
years. The elevated incidence may be owing,
primarily, to the higher incidence of adverse
pregnancy and labor outcomes including mul-
tiple births.
Population-level studies in Denmark and
Sweden failed to find a statistically significant
difference in risk for autism from IVF, but they
did find elevated risk in certain subgroups, for
example, girls18 and children resulting from
certain types of IVF procedures.22 We also
found a higher point estimate for the female
subgroup; however, it did not differ statistically
from the estimate for boys. Another study
found no association between multiple births
and autism estimated prevalence (although it
did show elevated estimated prevalence of
cerebral palsy) among 1994 US births,19 which
contrasts with our finding of elevated rates of
diagnosed autism among multiple births.
The stratified analyses showed statistically
significant associations between autism and
ART in most subgroups; yet, in general, ART
appeared to add less risk for groups whose
pregnancies were already at higher risk for
autism, such as male infants, older parents,
primiparous mothers, and those with more
education. There are many potential mecha-
nisms through which ART could be associated
with autism, including the biological factors
related to the underlying fertility or quality of
the germ cells, effects of the fertility hormones
used during ART, other effects of the ART
procedure, and the prenatal and perinatal
complications associated with ART treat-
ment.24 We did not design this study to
distinguish between most of these mechanisms.
Yet on the basis of the evidence, we suspect
that the elevated incidence we observed may
come through the causal pathway of increasing
adverse labor and pregnancy outcomes. That
is, although ART may be associated with
autism in part because mothers who use ART
are older and more likely to be primiparous
(indicating a possible role for underlying in-
fertility), ART also may increase the chance of
other, intermediate autism risk factors.
We found that multiple births played an
important role in the association between ART
and autism—in fact, the adjusted risk arising
from ART was not significantly elevated among
singletons (who make up less than half of
ART-originated children). Twin and higher-
order multiple births are a direct (although not
necessary) consequence of ART procedures.
Preterm and small for gestation age births,
diabetes, hypertension, and cesarean deliveries
also appear to be mediating factors in the
ART---autism association; however, this effect
may be indirect, by producing risky pregnan-
cies that, without ART, would not have oc-
curred. The mechanisms behind this associa-
tion require further investigation.
A key advantage of our study is its size,
which provides greater statistical power than
any previous analysis. We included more than
twice as many children, 7 times as many autism
Note. ART = assisted reproductive technology; CI = confidence interval; HRR = hazard risk ratio. The figure includes
unadjusted, adjusted, and strata-specific estimates. Model 1 adjusts for demographics, including birth year, infant gender,
and maternal race, education, and place of birth. Model 2 adjusts for all variables in model 1 plus maternal age and parity.
Model 3 adjusts for model 2 variables plus adverse perinatal outcomes (multiple birth, preterm, small for gestational age,
maternal diabetes, hypertension and preeclampsia, and cesarean delivery). Stratified results adjust for all model 2 variables,
except the stratification variable. As the association was notably higher among the subgroup with younger maternal ages, we
have presented all stratified results for the younger maternal age subgroup only, except when stratifying by maternal age.
Because of missing data on paternal age, the sample size for that stratified model is n = 2 375 846. We conducted
interaction tests by interacting the stratification variable with ART.
*P < .05.
FIGURE 2—HRR (95% CI) for autism among ART-originated and non–ART-originated children
estimated for all births and the analysis subset: California, 1997–2007.
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diagnoses, and 6% more IVF exposures than did
the largest previous study. Significantly, this means
that these data included nearly 6 times as many
children born from IVF and diagnosed with
autism, which enabled us to producemore efficient
estimates, particularly for adjusted models.
In addition, differences between the US and
Scandinavian countries in procedures in which
multiple embryos are transferred means that this
study was better positioned to address the role
of multiple births. In Sweden since 2003, the
majority of ART procedures have involved
single-embryo transfer, and the rate of multiple
births has declined as a result.50 Differences
between this study and the Scandinavian studies
suggest that the impact of ART on autism risk can
vary by region, perhaps as a result of differing
usage patterns, which highlights the need for
more research. We did not examine the associa-
tion between autism and specific types of ART
procedures or infertility diagnoses, an obvious
area for future research that will help us un-
derstand the mechanisms of association.
Limitations
Our study did have several limitations. We
constructed our data through 2 imperfect linking
procedures, which may have biased results. In
addition, enrollment in the DDS is voluntary and
so may omit some eligible children with autism.
Although estimates of autism incidence as de-
termined by the DDS are consistent with other
population-based estimates,1 at best this is in-
cidence of diagnosed autism. Moreover, the DDS
requirement for diagnosis of autistic disorder to
receive services further limits inference to chil-
dren with other ASDs and would miss any
potential association between ART and milder
conditions on the autism spectrum.
In our analysis, we could not distinguish
between mechanisms arising from the ART
procedure itself and any preexisting biological
differences associated with infertility. Finally,
as with all observational studies, it is possible
that we did not include unmeasured demo-
graphic or parental characteristics in our lim-
ited socioeconomic status measures that may
be responsible for the observed association.
Conclusions
We have provided evidence of an elevated
incidence of diagnosed autism among children
originated by ART, and we have found that
multiple births and complications of pregnancy
and delivery likely play mediating roles in the
association. Increased incidence of autism per-
sisted after adjustment for confounders as well as
in most subgroups except singleton children.
Adjusting for adverse prenatal and perinatal
complications, including multiple births, reduced
the association between ART and autism for
younger mothers and eliminated it for older
mothers. Although the precise mechanism is un-
clear, these results suggest that children born as
a result of ART may have an elevated incidence
of autism potentially because of the link between
ART and adverse pregnancy and labor outcomes,
especially multiple births. Although more re-
search is needed, this suggests that single-embryo
transfer,13,51 when appropriate, may reduce the
risk of autism among ART-originated infants. j
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